MetLife (MET) Stock Buyback History
TTM buyback yield 5.49% · Shareholder yield (TTM) 5.49%.
MetLife
MET
TTM buyback yield
5.49%
Shareholder yield (TTM)
5.49%
5Y share count change
-27.2%
TTM buyback spend
$2.88B
SBC coverage (TTM)
N/A
Diluted vs basic shares (annual)
Weighted average shares from the income statement: diluted (EPS denominator and typical buyback-yield basis) compared with basic.
Shares outstanding (annual)
Year-over-year change in diluted weighted average shares (industry-standard for EPS and per-share capital return). Green is fewer shares vs the prior fiscal year; red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield
Buybacks vs stock-based compensation
TTM coverage: N/A (buybacks ÷ SBC). Bars are fiscal-year totals.
Buyback spending history
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2025 | $3.88B | $0.00 | $3.88B | 0.66B | -6.5% | 7.40% |
| 2024 | $3.21B | $0.00 | $3.21B | 0.71B | -6.7% | 5.63% |
| 2023 | $3.10B | $0.00 | $3.10B | 0.76B | -5.7% | 6.29% |
| 2022 | $3.33B | $0.00 | $3.33B | 0.81B | -7.0% | 5.90% |
| 2021 | $4.80B | $0.00 | $4.80B | 0.87B | -4.8% | 9.17% |
| 2020 | $2.15B | $0.00 | $2.15B | 0.91B | -3.3% | 5.10% |
| 2019 | $2.29B | $0.00 | $2.29B | 0.94B | -6.9% | 4.88% |
| 2018 | $3.99B | $0.00 | $3.99B | 1.01B | -2.8% | 9.92% |
| 2017 | $2.93B | $0.00 | $2.93B | 1.04B | -4.7% | 5.50% |
| 2016 | $372.00M | $0.00 | $372.00M | 1.10B | -2.9% | 0.70% |
| 2015 | $3.43B | $0.00 | $3.43B | 1.13B | -0.3% | 7.19% |
| 2014 | $1.00B | $0.00 | $1.00B | 1.13B | 0.9% | 1.83% |
| 2013 | $0.00 | $0.00 | $0.00 | 1.12B | 2.8% | — |
| 2012 | $0.00 | $0.00 | $0.00 | 1.09B | 3.2% | — |
| 2011 | $2.95B | $0.00 | $2.95B | 1.06B | 7.3% | — |
| 2010 | $0.00 | $0.00 | $0.00 | 0.99B | 20.5% | — |
| 2009 | $0.00 | $0.00 | $0.00 | 0.82B | 9.9% | — |
| 2008 | $1.25B | $0.00 | $1.25B | 0.74B | -2.3% | — |
| 2007 | $1.71B | $0.00 | $1.71B | 0.76B | -1.1% | — |
| 2006 | $500.00M | $0.00 | $500.00M | 0.77B | 2.1% | — |
| 2005 | $0.00 | $0.00 | $0.00 | 0.76B | 0.0% | — |
| 2004 | $1.00B | $0.00 | $1.00B | 0.75B | 1.1% | — |
| 2003 | $97.00M | $0.00 | $97.00M | 0.75B | 2.4% | — |
| 2002 | $471.00M | $0.00 | $471.00M | 0.73B | -4.4% | — |
| 2001 | $1.32B | $0.00 | $1.32B | 0.76B | 19.3% | — |
| 2000 | $613.00M | $0.00 | $613.00M | 0.64B | -18.3% | — |
| 1999 | $0.00 | $0.00 | $0.00 | 0.78B | 0.0% | — |
| 1998 | $0.00 | $0.00 | $0.00 | 0.78B | 5.0% | — |
| 1997 | $0.00 | $0.00 | $0.00 | 0.74B | — | — |
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
TTM buybacks vs headroom (FCF − dividends, TTM)17% of headroom
Headroom $16.60B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Does MetLife buy back its own stock?
- Yes, MetLife (MET) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
How much does MetLife spend on share buybacks?
- Trailing twelve months (TTM) buyback spend is about $2.88B (sum of the last four quarterly cash-flow periods in our data). Figures are illustrative; verify in filings.
What is MetLife's buyback yield?
- TTM buyback yield is about 5.49% (TTM buyback spend divided by market cap at the latest quarter-end in our data).
What is MetLife's shareholder yield?
- Shareholder yield combines dividend yield and buyback yield. For the latest period we show approximately 5.49% combined (TTM-based where available).
Is MetLife diluting shareholders?
- Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has MetLife's share count changed?
- Diluted weighted average shares changed by about -27.2% over roughly five fiscal years (annual income statement data).